CU06-1004 - CAS 1296734-08-1

CU06-1004 (Sac-1004) is an orally active compound that mitigates endothelial dysfunction by inhibiting hyperpermeability and inflammation. It reduces vascular leakage and inflammation in multiple animal models, including diabetic retinopathy, stroke, cancer, and inflammatory bowel disease. CU06-1004 also improves conditions in a CDAA-induced mouse model of NASH and enhances cardiac function [1] [2] [3].

Others

Others

1296734-08-1

C37H54O8

626.82

C[C@@]12[C@]([C@]3([C@@]([C@]4(C)C(=CC3)C[C@@H](OC5O[C@H](COC(C)=O)[C@@H](OC(C)=O)C=C5)CC4)(CC1)[H])[H])(CC[C@@H]2\C(=C\CCCC(OC)=O)\C)[H]

-20°C

Ice Packs

Small Compound